Rx (Prescription Medicine)
USD $ 59.00
Pazotab 400mg Tablet 是一种含有帕兹帕尼（Pazopanib）作为活性成分的药物。帕兹帕尼属于一种靶向治疗药物，称为酪氨酸激酶抑制剂。它通过阻断参与癌细胞生长和转移的特定酶的活性发挥作用。通过抑制这些酶，Pazotab 有助于减缓或停止肿瘤的生长，同时还能减少为癌症提供血液供应的新血管的形成。
Pazotab 400mg Tablet 主要用于治疗晚期肾细胞癌（肾癌）和在先前接受化疗后的成人软组织肉瘤。常规剂量为 800mg，每日两次，空腹服用。务必遵循医生关于剂量和治疗时长的指示。不要自行停止服用 Pazotab，如需停药请先咨询您的医疗提供者。
常见的不良反应可能包括腹泻、恶心、呕吐、疲劳、头发颜色改变以及血压升高。虽然较少见但可能出现更严重的不良反应。出现任何新症状或原有症状加重，请立即向医生报告。Pazotab 应储存在室温，远离潮湿和热源，并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Pazopanib 400 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
